From Glycan Biology to Drug Candidates: An Integrated Sialylation Niche Index and AI-Guided Therapeutic Framework for Head and Neck Squamous Cell Carcinoma
Open Access
- 17 September 2026
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 14 (9) , 2102
Abstract
Background: Head and neck squamous cell carcinoma (HNSCC) responds poorly (n = 501) were analysed with a 1204-gene sialylation compendium. The Sialylation Niche Index (SNI) was built in TCGA-HNSC from 117 machine-learning algorithm combinations (nominally 101), with survival-based feature selection and model fitting confined to the training set; model selection used TCGA-HNSC and the external model-selection cohort GSE42743 (n = 74 with overall survival), and the three independent test cohorts were scored without re-fitting (E-MTAB-8588, n = 83; GSE65858, n = 270; and GSE41613, n = 97). Key model genes were characterised by single-cell RNA sequencing (168,742 cells), spatial transcriptomics, and AI-guided screening of 249,455 compounds. Results: Thirty-one prognostic sialylation-associated DEGs defined an immunosuppressive subtype (C1) and an immune-active subtype (C2) with divergent survival. The SNI achieved a C-index of 0.88 in TCGA-HNSC, 0.68 in GSE42743, and 0.58–0.62 in the three independent test cohorts and remained independently prognostic after adjustment for age and other clinicopathological variables in multivariable analysis. SHAP analysis identified HSPH1 (risk-associated) and ST6GALNAC1 (protective) as principal contributors with opposing microenvironmental associations. Conclusions: Sialylation constitutes a distinct immunosuppressive axis in HNSCC, complementary to PD-1 blockade. The SNI provides a biologically anchored prognostic framework whose cross-platform transfer requires recalibration; putative candidate compounds require experimental validation.Keywords
Funding Information
- National High Level Hospital Clinical Research Funding (2022-PUMCH-B-094)
This publication has 64 references indexed in Scilit:
- Machine learning explainability for survival outcome in head and neck squamous cell carcinomaInternational Journal of Medical Informatics, 2025
- Mime: A flexible machine-learning framework to construct and visualize models for clinical characteristics prediction and feature selectionComputational and Structural Biotechnology Journal, 2024
- Overview of AlphaFold2 and breakthroughs in overcoming its limitationsComputers in Biology and Medicine, 2024
- Extracellular vesicles related gene HSPH1 exerts anti-tumor effects in prostate cancer via promoting the stress response of CD8 + T cellsCellular Oncology, 2024
- How good are AlphaFold models for docking-based virtual screening?iScience, 2022
- Head and neck cancer N-glycome traits are cell line and HPV status–dependentAnalytical and Bioanalytical Chemistry, 2022
- ST6GalNAc‐I promotes lung cancer metastasis by altering MUC5AC sialylationMolecular Oncology, 2021
- Immune checkpoint expression in HNSCC patients before and after definitive chemoradiotherapyHead & Neck, 2020
- Correction to: The old CEACAMs find their new role in tumor immunotherapyInvestigational New Drugs, 2020
- The role of HPV RNA transcription, immune response‐related gene expression and disruptiveTP53mutations in diagnostic and prognostic profiling of head and neck cancerInternational Journal of Cancer, 2015